Results 101 to 110 of about 12,443,450 (160)

The Spectrum of Type III Hyperlipoproteinemia

Journal of Clinical Lipidology, 2018
BACKGROUND: Type III hyperlipoproteinemia is a highly atherogenic dyslipoproteinemia characterized by hypercholesterolemia and hypertriglyceridemia due to markedly increased numbers of cholesterol-enriched chylomicron and very-low-density lipoprotein ...
Jacqueline de Graaf, Allan D Sniderman
exaly   +2 more sources

Type 1 Hyperlipoproteinemia Due to a Novel Deletion of Exons 3 and 4 in the GPIHBP1 Gene

Atherosclerosis, 2014
Objectives: Type 1 hyperlipoproteinemia is an autosomal recessive disorder characterized by severely elevated plasma triglyceride levels, which may lead to abdominal pain and pancreatitis, eruptive xanthomas and failure to thrive.
Stefano Romeo, Kjetil Retterstøl, Trond P Leren   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Clofibrate in Type II Hyperlipoproteinemia

Acta Medica Scandinavica, 1976
ABSTRACT. As part of a double‐blind randomized study, the safety and the lipid‐ and uric acid‐lowering effect of clofibrate have been evaluated in 28 patients with type II hyperlipoproteinemia (HLP). A highly significant reduction of serum cholesterol occurred in type II a and of serum triglyceride and cholesterol in type IIb HLP throughout the 60 ...
J, Ditzel, H O, Bang
openaire   +2 more sources

Pseudohomozygous type II hyperlipoproteinemia

The Journal of Pediatrics, 1974
Familial hypercholesterolemia (a form of familial type II hyperlipoproteinemia) is transmitted as a dominant trait with homozygotes presenting in childhood with marked elevation of LDL and planar xanthormas. We studied two patients who presented as children with marked elevation of LDL and planar xanthomas but who, after family studies and clinical ...
J, Morganroth, R I, Levy, A E, McMahon, A M, Gotto   +3 more
openaire   +2 more sources

Sitosterol in juvenile type II hyperlipoproteinemia

Atherosclerosis, 1978
The effect of beta-sitosterol on plasma lipids and lipoproteins was evaluated in a randomized double-blind cross-over trial in 15 children and adolescents with familial hypercholesterolemia over a period of 6 months. Twelve patients completed the study, with good adherence to drug intake.
G, Schlierf, P, Oster, C C, Heuck, H, Raetzer, B, Schellenberg   +4 more
openaire   +2 more sources

Results of colestipol therapy in type II hyperlipoproteinemia

Atherosclerosis, 1976
Twenty-five patinets with well defined Type ii hyperlipoproteinemia were treated with a divided 15 g daily dose of colestipol, a bile acid sequestrant, for periods of up to 20 months. The patients were divided into 3 groups: Those with no obvious sequelae, those with arcus corneae, xanthomas, and/or xanthelasmas only, and those with atherosclerotic ...
A M, Lees, M A, McCluskey, R S, Lees
openaire   +2 more sources

Type II hyperlipoproteinaemia

Clinics in Endocrinology and Metabolism, 1973
Type II hyperlipoproteinemia is characterized by an abnormally high plasma β-lipoprotein concentration. Hence, an alternative name for the Type II lipoprotein pattern is hyper-β-lipoproteinemia. Although this pattern commonly occurs in the absence of any other lipoprotein abnormality, it may also occur in association with a raised concentration of ...
N B, Myant, J, Slack
openaire   +2 more sources

Special Diet for Familial Type II Hyperlipoproteinemia

Archives of Pediatrics & Adolescent Medicine, 1974
A suggested diet containing less than 200 mg cholesterol per day, with a polyunsaturate: saturate ratio of 0.9:1 was prepared for young children with familial hypercholesterolemia. A representative meal plan and calculations for a seven-day food intake allow for a practical, economical diet, low in cholesterol and saturated fat, but high in essential ...
R, Larsen, C J, Glueck, R, Tsang
openaire   +2 more sources

Kyrle's Disease and Type II Hyperlipoproteinemia

Archives of Dermatology, 1980
Kyrle's disease is an uncommon dermatosis of hyperkeratotic papules, with a distinctive histologic picture characterized by the penetration of a keratotic plug into the dermis. We report a case of Kyrle's disease in association with type II hyperlipoproteinemia.
K J, Tomecki, J W, Battaglini, J C, Maize   +2 more
openaire   +3 more sources

Hypertrophy of Liver Peroxisomes in Type II and Type IV Hyperlipoproteinemia

Atherosclerosis, 1986
A morphometric study on liver biopsies from patients with primary hyperlipoproteinemia (IIa n = 4, IIb n = 7, IV n = 7) and in controls (n = 7) was performed by light and electron microscopy. We found hypertrophy of peroxisomes in all subjects with hyperlipoproteinemia.
P Drouin, P Genton, G Debry
exaly   +3 more sources